ConductScience.org, home

Trial · NCT07216742

Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.

NCT07216742, Phase 3, Active not recruiting, Granata Bio Corporation

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer. Trials, record NCT07216742. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07216742

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Human Menopausal Gonadotropin Research in Infertility Assessing Cumulative Live Birth With Frozen Embryo Transfer.
NCT number
NCT07216742
Status
Active not recruiting
Phases
Phase 3
Enrollment
659 participants, estimated
Lead sponsor
Granata Bio Corporation
Conditions
Infertility (IVF Patients)
Interventions
hMG subcutaneous injection, Placebo
First posted
2025-10-15
Last updated
2026-11-05

Source ClinicalTrials.gov

Registered outcomes41

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
Primarycumulative live birth rate12 monthscumulative live birth rate following vitrified-thawed, single-euploid blastocyst transfer(s)
SecondaryPositive pregnancy (serum β-human chorionic gonadotropin [hCG])10 +/-2 days after Embryo transfer
SecondaryClinical pregnancy (intrauterine gestational sac with fetal heartbeat)5 weeks ± 6 days post-embryo transfer
SecondaryOngoing pregnancy (intrauterine pregnancy with fetal heartbeat)10 weeks ± 6 days post-embryo transfer (ET)
SecondaryLive birth rate9 months after ET
SecondaryNumber of oocytes retrieved per stimulation cycle12-22 days after controlled ovarian stimulation start
SecondaryNumber of metaphase II (MII) oocytes retrieved12-22 days after controlled ovarian stimulation start
SecondaryFertilization rate (proportion of MII oocytes with normal fertilization)12-22 days after Controlled Ovarian stimulation start
SecondaryNumber of Day 5 blastocysts from oocyte retrievals from Period 1 and Period 212-22 days after controlled ovarian stimulation start
SecondaryTotal gonadotropin dose required per stimulation cycle12-20 days after start Controlled ovarian stimulation

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07216742

GET https://conductscience.org/api/trials/v1/NCT07216742/registered?page=2